newsOnce built, the new manufacturing facility in Berlin is anticipated…
11 April 2024 | By Catherine Eckford (European Pharmaceutical Review)
Once built, the new manufacturing facility in Berlin is anticipated to help drive the production of high-quality oligonucleotide therapeutics.